Delivery Order SPE2DB22D3016-SPE2DB25FBEP1
- Not listed
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $36,331.88 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity: 30 units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement of pharmaceutical supplies for federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $26,109.77 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,327.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count unit dosage) with a firm fixed price structure. The award, issued on July 31, 2025, is set to be completed by August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- The Defense Logistics Agency awarded a $8,032.69 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with performance scheduled for completion by August 21, 2025, and fulfillment based at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,898.04 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract, executed without set-aside provisions, represents a competitively awarded procurement under the agency's pharmaceutical supply chain. The award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $24,376.15 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $14,991.82 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through full and open competition. This delivery order is issued...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEP1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,577.96 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30. This competitive award, which will be completed by August 12, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same municipality. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The current order for DESCOVY, an antiretroviral medication, exemplifies the company's role in fulfilling critical pharmaceutical needs within the federal healthcare supply chain through competitively awarded delivery orders at firm fixed prices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.6k | 8/11/25 |